DEA Warns Of Crackdown On Ketamine Prescribing Following Matthew Perry’s Death

The death of “Friends” actor Matthew Perry has spurred the Drug Enforcement Administration (DEA) into action. The agency is drawing alarming parallels between the rise in ketamine use and the early days of the opioid epidemic. As Double Blind reported, the DEA is now signaling a potential crackdown on what it describes as “ketamine pill mills,” sparking a heated debate within the medical and psychedelic communities.

Read Also: Matthew Perry’s Assistant, Doctors Charged With Supplying Ketamine To ‘Friends’ Star, Aiding In Overdose Death (UPDATED)

Rise Of Ketamine In Medicine And Popular Culture

In a recent statement, DEA Administrator Anne Milgram expressed concern over the increasing availability of ketamine, a drug that has traditionally not been at the forefront of the drug war. “Every single day, we are targeting and investigating doctors, nurse practitioners, others, who are violating this duty of trust to their patients by overprescribing medicine or prescribing medicine that isn’t necessary,” Milgram told CBS. The DEA’s investigation revealed that Matthew Perry was charged around $50,000 over one month for a …

Full story available on Benzinga.com